|
BNIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.580600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.648600E-01 |
| Normal-vs-Stage2 |
3.359200E-01 |
| Normal-vs-Stage3 |
5.680000E-01 |
| Normal-vs-Stage4 |
8.537200E-01 |
| Stage1-vs-Stage2 |
4.339200E-01 |
| Stage1-vs-Stage3 |
7.919600E-01 |
| Stage1-vs-Stage4 |
9.646400E-01 |
| Stage2-vs-Stage3 |
6.333000E-01 |
| Stage2-vs-Stage4 |
6.057400E-01 |
| Stage3-vs-Stage4 |
8.400000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.242800E-01 |
| Normal-vs-AfricanAmerican |
2.474400E-01 |
| Normal-vs-Asian |
7.215000E-01 |
| Caucasian-vs-AfricanAmerican |
4.103200E-01 |
| Caucasian-vs-Asian |
2.918000E-01 |
| AfricanAmerican-vs-Asian |
1.480390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.321400E-01 |
| Normal-vs-Female |
9.270100E-02 |
| Male-vs-Female |
8.077600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.307200E-01 |
| Normal-vs-Extreme_Weight |
5.773400E-01 |
| Normal-vs-Obese |
2.026800E-01 |
| Normal-vs-Extreme_Obese |
1.066420E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.748000E-01 |
| Normal_Weight-vs-Obese |
3.241000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.358370E-01 |
| Extreme_Weight-vs-Obese |
4.217200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.210630E-01 |
| Obese-vs-Extreme_Obese |
5.374000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.685800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.203900E-02 |
| Normal-vs-Age(61-80Yrs) |
9.182400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.086950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.984000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.646500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.736300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.262250E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.642110E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.660970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.690300E-02 |
| Normal-VS-Type2 PRCC |
6.222200E-03 |
| Normal-VS-KIRP CIMP |
1.099840E-02 |
| Normal-VS-Unclassified PRCC |
2.157000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.79509998374539E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.161800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.992200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.63120000000028E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.967800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.682010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.374600E-01 |
| Normal-vs-N1 |
3.669400E-01 |
| Normal-vs-N2 |
4.912000E-01 |
| N0-vs-N1 |
5.569700E-02 |
| N0-vs-N2 |
8.910800E-01 |
| N1-vs-N2 |
3.627800E-01 |
|
|
